Literature DB >> 14718836

Clinical and social consequences of Buerger disease.

Takashi Ohta1, Hiroyuki Ishioashi, Minoru Hosaka, Ikuo Sugimoto.   

Abstract

PURPOSE: This study was undertaken to assess the clinical course of Buerger disease and to analyze the social problems that influence quality of life of affected patients. PATIENTS AND METHODS: One hundred ten patients with Buerger disease (106 men, 4 women; mean age, 40.0 years) for whom complete data since onset of disease were available were included in this retrospective study (mean follow-up, 10.6 years). Data were obtained by means of direct interview, written reports, or telephone. Data for deceased subjects were gathered from their families via written report or telephone. Graft patency was evaluated by means of ankle pressure measurement; and in all patients with decreased ankle pressure arteriography was performed.
RESULTS: Seven of 110 study patients (6%) died during follow-up. Cumulative survival rate was 84% up to 25 years after the initial consultation. Results of bypass operations (n = 46) were not satisfactory. Primary graft patency was 41% at 1 year after operation, 32% at 5 years, and 30% at 10 years. Secondary graft patency was 54% at 1 year of follow-up, 47% at 5 years, and 39% at 10 years. However, major amputation was necessary in only 5 of 35 limbs (14%) with failed grafts. Forty-seven patients (43%) underwent 108 amputation procedures, either major amputation (13 patients) or minor amputation (34 patients), of an upper or lower limb. No ischemic ulcers occurred or recurred in patients older than 60 years. Forty-one patients who stopped smoking did not undergo major amputation. Furthermore, of 69 patients who continued smoking, 13 patients (19%) underwent major amputation. There was a correlation between incidence of continued smoking and limb amputation (P =.0070). In addition, 11 of 13 patients who underwent major lower limb amputation (85%) lost their job, compared with 9 of 97 patients without major amputation (9%). There was an association between limb amputation and job loss (P <.0001). All patients who lost their jobs were engaged in manual labor.
CONCLUSION: The natural course of life and limb is favorable in many patients with Buerger disease. Occurrence or recurrence of necrotic lesions usually is arrested in patients older than 60 years. To avoid factors that markedly influence quality of life, early treatment and strict instruction to prohibit smoking are mandatory. Arterial reconstruction shortens the healing process of ischemic ulcers, despite poor long-term results. However, bypass surgery to treat intermittent claudication should be limited.

Entities:  

Mesh:

Year:  2004        PMID: 14718836     DOI: 10.1016/j.jvs.2003.08.006

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  30 in total

1.  A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease.

Authors:  Jeong Chan Ra; Euicheol C Jeong; Sung Keun Kang; Seog Ju Lee; Kyoung Ho Choi
Journal:  Cell Med       Date:  2016-10-03

2.  Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue.

Authors:  Kosmas I Paraskevas
Journal:  Clin Rheumatol       Date:  2008-02-02       Impact factor: 2.980

3.  Decrease in the incidence of Buerger's disease recurrence in northern Thailand.

Authors:  Kamphol Laohapensang; Kittipan Rerkasem; Vinaisak Kattipattanapong
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Fate of ischemic limbs in patients with Buerger's disease based on our 30-year experience: does smoking have a definitive impact on the late loss of limbs?

Authors:  Masayuki Sugimoto; Hiroki Miyachi; Hirofumi Morimae; Akio Kodama; Hiroshi Narita; Hiroshi Banno; Kiyohito Yamamoto; Kimihiro Komori
Journal:  Surg Today       Date:  2014-04-26       Impact factor: 2.549

5.  Buerger's Disease (Thromboangiitis Obliterans)- Management by Ilizarov's Technique of Horizontal Distraction. A Retrospective Study of 60 Cases.

Authors:  Jagdish Jashwantlal Patwa; Ajay Krishnan
Journal:  Indian J Surg       Date:  2010-12-14       Impact factor: 0.656

Review 6.  Thromboangiitis obliterans.

Authors:  Gregory Piazza; Mark A Creager
Journal:  Circulation       Date:  2010-04-27       Impact factor: 29.690

7.  Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan.

Authors:  Joaquin De Haro; Francisco Acin; Silvia Bleda; Cesar Varela; Leticia Esparza
Journal:  BMC Cardiovasc Disord       Date:  2012-02-14       Impact factor: 2.298

8.  Cell therapy for critical limb ischemia: moving forward one step at a time.

Authors:  Rajesh Gupta; Douglas W Losordo
Journal:  Circ Cardiovasc Interv       Date:  2011-02-01       Impact factor: 6.546

9.  Buerger's disease: a multidisciplinary diagnostic and therapeutic challenge.

Authors:  Nassim Parvizi; Joseph Shalhoub; Alun H Davies
Journal:  JRSM Short Rep       Date:  2010-06-30

Review 10.  Current status of patients with buerger disease in Japan.

Authors:  Noriyuki Hida; Takashi Ohta
Journal:  Ann Vasc Dis       Date:  2013-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.